Travoprost Ophthalmic Solution IP is a prescription eye drop used to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension. Formulated with Travoprost 0.004% w/v, a prostaglandin analogue, it works by increasing the outflow of aqueous humor from the eye, effectively lowering IOP and reducing the risk of optic nerve damage and vision loss. This advanced formulation helps protect long-term eye health and is widely recommended as a first-line therapy for glaucoma management.
Travoprost 0.004% w/v: A prostaglandin analogue that enhances aqueous humor drainage to lower eye pressure and prevent progression of glaucoma.
Effective Control of High IOP: Reduces elevated intraocular pressure in glaucoma and ocular hypertension.
Prevents Vision Loss: Helps protect the optic nerve from pressure-related damage.
Once-Daily Convenient Dosing: Ensures patient compliance and sustained eye pressure control.
Trusted Ophthalmic Quality: Formulated under strict sterile conditions for safety and reliability.
Instill the prescribed number of drops into the affected eye(s), usually once daily in the evening or as directed by an ophthalmologist. Avoid touching the dropper tip to prevent contamination.
May include mild eye irritation, redness, dryness, itching, or gradual darkening of the iris or eyelashes. Report severe or unusual symptoms to an eye care professional.
Globus Labs brings you WHO-GMP–certified, high-quality Travoprost eye-drop sourced from reputed pharmaceutical manufacturers. Travocet is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.